The stalk domain of NKp30 contributes to ligand binding and signaling of a preassembled NKp30-CD3ζ complex

Journal of Biological Chemistry

Volumn 291, Issue 49, 2016, Pages 25427-25438

  Memmer, Stefanie ^a,b   Weil, Sandra ^a,b   Beyer, Steffen ^b   Zöller, Tobias ^c   Peters, Eike ^b,d   Hartmann, Jessica ^e   Steinle, Alexander ^c   Koch, Joachim ^a,b,f  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d ETH ZURICH   (Switzerland)

^e PAUL EHRLICH INSTITUT   (Germany)

^f LOEWE Center for Cell and Gene Therapy   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BINS; CELL MEMBRANES; LIGANDS;

ASPARTATE RESIDUE; IMMUNOSURVEILLANCE; LIGAND BINDING; LIGAND RECOGNITION; MEMBRANE INTERFACE; N-GLYCOSYLATION; NATURAL CYTOTOXICITY RECEPTORS; RECEPTOR SIGNALING;

SIGNALING;

BINDING PROTEIN; CD3ZETA PROTEIN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; UNCLASSIFIED DRUG; CD3 ANTIGEN; CD3E PROTEIN, HUMAN; NCR1 PROTEIN, HUMAN; NCR3 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; ANIMAL; CELL MEMBRANE; GENETICS; HELA CELL LINE; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD3; CELL MEMBRANE; HELA CELLS; HUMANS; MICE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; PROTEIN DOMAINS; SIGNAL TRANSDUCTION;

EID: 85002271124     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.742981     Document Type: Article

References (41)

1. Imai, K., Matsuyama, S., Miyake, S., Suga, K., and Nakachi, K. (2000) Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356, 1795-1799
2. Koch, J., Steinle, A., Watzl, C., and Mandelboim, O. (2013) Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol. 34, 182-191
3. Lanier, L. L. (2005) NKcell recognition. Annu. Rev. Immunol. 23, 225-274
4. Vivier, E., Tomasello, E., Baratin, M., Walzer, T., and Ugolini, S. (2008) Functions of natural killer cells. Nat. Immunol. 9, 503-510
5. Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., and Brossay, L. (2012) Targeting natural killer cells and natural killer T cells in cancer. Nat. Rev. Immunol. 12, 239-252
6. Farag, S. S., and Caligiuri, M. A. (2006) Human natural killer cell development and biology. Blood Rev. 20, 123-137
7. Moretta, L., Bottino, C., Pende, D., Castriconi, R., Mingari, M. C., and Moretta, A. (2006) Surface NK receptors and their ligands on tumor cells. Semin. Immunol. 18, 151-158
8. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., and Spies, T. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729
9. Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., Bottino, C., Moretta, L., and Moretta, A. (1999) Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190, 1505-1516
10. Cantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., and Biassoni, R. (1999) NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 189, 787-796
11. Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., and Moretta, A. (1998) NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187, 2065-2072
12. Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., and Moretta, A. (1998) Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188, 953-960
13. Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., and Moretta, A. (1997) p46, a novel natural killer cellspecific surface molecule that mediates cell activation. J. Exp. Med. 186, 1129-1136
14. Brandt, C. S., Baratin, M., Yi, E. C., Kennedy, J., Gao, Z., Fox, B., Haldeman, B., Ostrander, C. D., Kaifu, T., Chabannon, C., Moretta, A., West, R., Xu, W., Vivier, E., and Levin, S. D. (2009) The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 206, 1495-1503
15. Binici, J., and Koch, J. (2014) BAG-6, a jack of all trades in health and disease. Cell. Mol. Life Sci. 71, 1829-1837
16. Pogge von Strandmann, E., Simhadri, V. R., von Tresckow, B., Sasse, S., Reiners, K. S., Hansen, H. P., Rothe, A., Böll, B., Simhadri, V. L., Borchmann, P., McKinnon, P. J., Hallek, M., and Engert, A. (2007) Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 27, 965-974
17. Wang, W., Guo, H., Geng, J., Zheng, X., Wei, H., Sun, R., and Tian, Z. (2014) Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack. J. Biol. Chem. 289, 33311-33319
18. Rosental, B., Brusilovsky, M., Hadad, U., Oz, D., Appel, M. Y., Afergan, F., Yossef, R., Rosenberg, L. A., Aharoni, A., Cerwenka, A., Campbell, K. S., Braiman, A., and Porgador, A. (2011) Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J. Immunol. 187, 5693-5702
19. Baychelier, F., Sennepin, A., Ermonval, M., Dorgham, K., Debré, P., and Vieillard, V. (2013) Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. Blood 122, 2935-2942
20. Tomasello, E., Desmoulins, P. O., Chemin, K., Guia, S., Cremer, H., Ortaldo, J., Love, P., Kaiserlian, D., and Vivier, E. (2000) Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 lossof-function mutant mice. Immunity 13, 355-364
21. Hall, C., Berkhout, B., Alarcon, B., Sancho, J., Wileman, T., and Terhorst, C. (1991) Requirements for cell surface expression of the human TCR/CD3 complex in non-T cells. Int. Immunol. 3, 359-368
22. Kappes, D. J., and Tonegawa, S. (1991) Surface expression of alternative forms of the TCR/CD3 complex. Proc. Natl. Acad. Sci. U.S.A. 88, 10619-10623
23. Sussman, J. J., Bonifacino, J. S., Lippincott-Schwartz, J., Weissman, A. M., Saito, T., Klausner, R. D., and Ashwell, J. D. (1988) Failure to synthesize the T cell CD3-ξ chain: structure and function of a partial T cell receptor complex. Cell 52, 85-95
24. Call, M. E., Schnell, J. R., Xu, C., Lutz, R. A., Chou, J. J., and Wucherpfennig, K. W. (2006) The structure of the ξξ transmembrane dimer reveals features essential for its assembly with the T cell receptor. Cell 127, 355-368
25. Arnaud, J., Chenu, C., Huchenq, A., Gouaillard, C., Kuhlmann, J., and Rubin, B. (1996) Defective interactions between TCR chains and CD3 heterodimers prevent membrane expression of TCR-αβ in human T cells. J. Immunol. 156, 2155-2162
26. Binici, J., Hartmann, J., Herrmann, J., Schreiber, C., Beyer, S., Güler, G., Vogel, V., Tumulka, F., Abele, R., Mäntele, W., and Koch, J. (2013) A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor dependent cytotoxicity of natural killer cells. J. Biol. Chem. 288, 34295-34303
27. Hartmann, J., Tran, T. V., Kaudeer, J., Oberle, K., Herrmann, J., Quagliano, I., Abel, T., Cohnen, A., Gatterdam, V., Jacobs, A., Wollscheid, B., Tampé, R., Watzl, C., Diefenbach, A., and Koch, J. (2012) The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding. J. Biol. Chem. 287, 31527-31539
28. Herrmann, J., Berberich, H., Hartmann, J., Beyer, S., Davies, K., and Koch, J. (2014) Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands. J. Biol. Chem. 289, 765-777
29. Cheung, J. C., and Reithmeier, R. A. (2005) Membrane integration and topology of the first transmembrane segment in normal and Southeast Asian ovalocytosis human erythrocyte anion exchanger 1. Mol. Membr. Biol. 22, 203-214
30. Hofmann, K., and Stoffel, W. (1993) TMBASE-a database of membrane spanning protein segments. Biol. Chem. Hoppe-Seyler 374, 166
31. Nilsson, I. M., and von Heijne, G. (1993) Determination of the distance between the oligosaccharyl transferase active site and the endoplasmic reticulum membrane. J. Biol. Chem. 268, 5798-5801
32. Popov, M., Li, J., and Reithmeier, R. A. (1999) Transmembrane folding of the human erythrocyte anion exchanger (AE1, Band 3) determined by scanning and insertional N-glycosylation mutagenesis. Biochem. J. 339, 269-279
33. Popov, M., Tam, L. Y., Li, J., and Reithmeier, R. A. (1997) Mapping the ends of transmembrane segments in a polytopic membrane protein: scanning N-glycosylation mutagenesis of extracytosolic loops in the anion exchanger, band 3. J. Biol. Chem. 272, 18325-18332
34. Cheung, J. C., and Reithmeier, R. A. (2007) Scanning N-glycosylation mutagenesis of membrane proteins. Methods 41, 451-459
35. Sun, Z. J., Kim, K. S., Wagner, G., and Reinherz, E. L. (2001) Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3∈γ heterodimer. Cell 105, 913-923
36. Joyce, M. G., Tran, P., Zhuravleva, M. A., Jaw, J., Colonna, M., and Sun, P. D. (2011) Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site. Proc. Natl. Acad. Sci. U.S.A. 108, 6223-6228
37. Li, Y., Wang, Q., and Mariuzza, R. A. (2011) Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6. J. Exp. Med. 208, 703-714
38. Smith-Garvin, J. E., Koretzky, G. A., and Jordan, M. S. (2009) T cell activation. Annu. Rev. Immunol. 27, 591-619
39. Bolliger, L., Johansson, B., and Palmer, E. (1997) The short extracellular domain of the T cell receptor ξ chain is involved in assembly and signal transduction. Mol. Immunol. 34, 819-827
40. John, S., Banting, G. S., Goodfellow, P. N., and Owen, M. J. (1989) Surface expression of the Tcell receptor complex requires charged residues within the α chain transmembrane region. Eur. J. Immunol. 19, 335-339
41. Aivazian, D., and Stern, L. J. (2000) Phosphorylation of T cell receptor ξ is regulated by a lipid dependent folding transition. Nat. Struct. Biol. 7, 1023-1026